2010 Fiscal Year Final Research Report
Development of a mouse model for post-polio-like syndrome by using pseudo poliovirus
| Project/Area Number |
19790347
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Virology
|
|---|
| Research Institution | National Institute of Infectious Diseases |
|---|
Principal Investigator |
ARITA Minetaro National Institute of Infectious Diseases, ウイルス第二部第二室, 主任研究官 (70356244)
|
|---|
| Project Period (FY) |
2007 – 2010
|
| Keywords | 病原性 |
|---|
| Research Abstract |
We established a mouse model that shows residual poliomyelitis-like paralysis by using poliovirus (PV) pseudovirus infection in PV receptor-expressing mouse (TgPVR21), and analyzed a long-term effect of paralysis in the mice. To identify\y possible host factor required for post-polio syndrome, we searched for ant-PV compounds that inhibit replication process of PV. TgPVR21 mice showed severe residual poliomyelitis-like paralysis after inoculation with PV pseudovirus of more than 4.1×10^6 infectious units. After 6 months with/without exercise stress, we could not identify post-polio like symptom that could be attributable to the paralysis and exercise stress. We identified GW5074 (Raf-1 inhibitor) as PV replication inhibitor, and several kinase inhibitors, including MEK1/2 inhibitors, EGFR inhibitor, PI3K inhibitor, that could cooperatively act with GW5074 to inhibit PV replication. We found that the viral resistance determinant to GW5074 was a similar mutation to an anti-picornavirus compound enviroxime with unknown inhibitory mechanism. Moreover, we identified phosphatidylinositol 4-kinase III beta (PI4KB) as the target of GW5074 for its anti-PV activity, and indicated that PI4KB is a target of enviroxime-like compounds for its anti-PV activity.
|
Research Products
(7 results)
